Skip to content
Research Article Open access CC BY 3.0

Formulation and Evaluation of Gel Forming Ocular Minitablets Containing Piroxicam

Abd EL–Gawad H. Abd EL–Gawad, Osama A. Soliman, Susan A. Barker, Germeen N.S. Girgis

Journal of Pharmaceutical Research International · pp. 141–167 · Published 6 Oct 2012

10.9734/BJPR/2012/1653

Abstract

Aims: The purpose of this in vitro and ex vivo study was to prepare and characterise ocular minitablets of piroxicam based on different polymeric matrices and to evaluate their potential to provide prolonged and controlled drug release to ocular tissues after surface administration. Study Design: Experimental study and ex-vivo study. Place and Duration of Study: School of Pharmacy, University of East Anglia, Norwich, Norfolk, UK, between July 2011 and March 2012. Methodology: A range of placebo minitablet formulations were prepared based on pharmaceutically-acceptable polymers of differing chemical and physical properties. These were evaluated using standard physical and visual imaging methods. A subset of placebo formulations was chosen to prepare medicated minitablets containing 5 %w/w piroxicam as a model drug. Three different in vitro methodologies were used to assess drug release from the minitablets. An ex vivo porcine ocular method was used to assess likely tissue distribution of the drug after surface ocular administration of the minitablets. Results: Minitablets were successfully produced from all formulations. The in vitro drug release profile was dependent on the chemistry of the polymer used, its hydration and swelling behaviour and to some extent, the methodology used for assessing the drug release profile. The ex vivo studies in porcine eyes suggested that the drug disposition was inversely related to the hydration and swelling behaviour of the polymer. Minitablets containing piroxicam based on Pluronic F127 showed the highest posterior segment ocular bioavailability of the formulations studied in the ex vivo model. Conversely, the more highly swelling minitablet formulations showed higher anterior segment bioavailability. Conclusions: Ocular minitablets containing 5 %w/w piroxicam were successfully produced from a range of polymer matrices. In vitro release was shown to be dependent on the physical and chemical properties of the polymers used as the basis of the minitablets. Posterior segment deposition in an ex vivo model was greatest in the formulation which showed limited hydration and swelling behaviour in a simulated ocular environment.

Ocular minitablets piroxicam HPMC Na-CMC pluronic F127 dissolution.

References (26)

  1. 1 Mechanisms of solute release from porous hydrophilic polymers [DOI]
  2. 2 Handbook of Pharmaceutical Excipients
  3. 3 Mucoadhesive polymeric platforms for controlled drug delivery [DOI]
  4. 4 Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A [DOI]
  5. 5 Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin [DOI]
  6. 6 Liposomes as delivery systems for antibiotics [DOI]
  7. 7 Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide [DOI]
  8. 8 Transscleral drug delivery for posterior segment disease [DOI]
  9. 9 Barrier analysis of periocular drug delivery to the posterior segment [DOI]
  10. 10 Adverse effects of topical antiglaucoma drugs on the ocular surface [DOI]
  11. 11 Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes [DOI]
  12. 12 Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability.
  13. 13 A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics [DOI]
  14. 14 Water uptake and relaxation processes in mixed unlimited swelling hydrogels [DOI]
  15. 15 Quantitative determination of piroxicam in a new formulation (piroxicam–β-cyclodextrin) by derivative UV spectrophotometric method and HPLC [DOI]
  16. 16 Physicochemical Factors Associated with Binding and Retention of Compounds in Ocular Melanin of Rats: Correlations Using Data from Whole-Body Autoradiography and Molecular Modeling for Multiple Linear Regression Analyses [DOI]
  17. 17 yCD/HPyCD Mixtures as Solubilizer: Solid-State Characterization and Sample Dexamethasone Eye Drop Suspension [DOI]
  18. 18 Evaluation of a mucoadhesive tablet for ocular use [DOI]
  19. 19 Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces [DOI]
  20. 20 Ocular Bioerodible Minitablets as Strategy for the Management of Microbial Keratitis [DOI]
  21. 21 Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol–starch components [DOI]
  22. 22 An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation [DOI]
  23. 23 Formulation and In-Vitro Evaluation of Ocular Ciprofloxacin-Containing Minitablets Prepared with Different Combinations of Carbopol 974P and Various Cellulose Derivatives.
  24. 24 Albumin Microspheres for Ocular Delivery of Piroxicam [DOI]
  25. 25 Effectiveness and Tolerance of Piroxicam 0.5% and Diclofenac Sodium 0.1% in Controlling Inflammation after Cataract Surgery [DOI]
  26. 26 Topical piroxicam and conjunctivitis.

Cited by 12

The Effect of Particle Size on the Physical Characteristics and Drug-release Behavior of Mini-tablets

Awis Sukarni Mohmad Sabere, M. Mahat · TRENDS IN THE SCIENCES · 2021

Chitosan: A Good Candidate for Sustained Release Ocular Drug Delivery Systems

L. Popa, M. Ghica, C. Dinu‐Pîrvu · Chitin-Chitosan - Myriad Functionalities in Science and Technology · 2018

Ophthalmic Drug Dosage Forms: Characterisation and Research Methods

P. Baranowski, B. Karolewicz, Maciej Gajda · TheScientificWorldJournal · 2014

Piroxicam.

Gamal A E Mostafa, A. S. Al-Dosseri, Abdullah A Al-Badr · Profiles of Drug Substances, Excipients and Related Methodology · 2020

Showing 7 of 12 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

26

Page views

0

PDF downloads

2

Outbound clicks

12

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.